Latest Reports

UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2026

The United States pharmaceutical continuous manufacturing market is anticipated to record a CAGR of 10.45%, by 2026. The country’s market growth is determined by factors such as, the initiatives introduced by government agencies, the presence of leading players, and the advantages of the free pricing policy. The base year considered for the studied market is 2020, while the forecast period is 2021 to 2026. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2026 United States Pharmaceutical... Read more

GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET FORECAST 2021-2028

The global irritable bowel syndrome treatment market is projected to register a CAGR of 7.25% and is anticipated to generate a revenue share of $1964.2 million by 2028. The base year considered for the market study is 2020, and the forecast years are 2021 to 2028. Irritable bowel syndrome (IBS) is a common disorder affecting the large intestine. It is also known as irritable colon, spastic colon, mucous colitis, and spastic colitis, and differs from... Read more

ASIA PACIFIC IRRITABLE BOWEL SYNDROME TREATMENT MARKET FORECAST 2021-2028

The Asia Pacific irritable bowel syndrome treatment market is set to project a CAGR of 8.92% during the forecast period, 2021-2028. The factors driving the market growth are the enhanced healthcare infrastructure, the increasing number of hospitals with advanced medical facilities, technological advancements, and the growing healthcare reforms. The Asia Pacific irritable bowel syndrome treatment market growth assessment includes the analysis of Indonesia, Australia & New Zealand, China, Japan, South Korea, Vietnam, India, Thailand, and Rest... Read more

EUROPE IRRITABLE BOWEL SYNDROME TREATMENT MARKET FORECAST 2021-2028

The Europe irritable bowel syndrome treatment market is estimated to project a CAGR of 7.16% during the forecast period, 2021-2028. The growing prevalence of gastrointestinal diseases like diarrhea and constipation, changing lifestyles, and the presence of key players, are driving market growth in the region. The Europe irritable bowel syndrome treatment market growth evaluation includes the analysis of France, the United Kingdom, Belgium, Germany, Russia, Poland, Italy, and Rest of Europe. EUROPE IRRITABLE BOWEL SYNDROME TREATMENT... Read more

NORTH AMERICA IRRITABLE BOWEL SYNDROME TREATMENT MARKET FORECAST 2021-2028

The North America irritable bowel syndrome treatment market is projected to record a CAGR of 6.36% during the forecast period, 2021-2028. The growing prevalence of irritable bowel syndrome and related conditions and the rising number of FDA approvals & drug developments are propelling the market growth. The North America irritable bowel syndrome treatment market growth assessment includes the analysis of the United States and Canada. According to the 2017 FDA data, there is a high prevalence... Read more